BeStock  
Stocks › Biotechnology › CRMD

CorMedix CRMD

US equityMarket cap rank #3659Biotechnology
$5.27 +$0.19 (+3.74%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $5.32 +0.95%
Open$4.96
Prev close$5.08
Day range$4.95 – $5.32
Volume3.61M
Market cap$419.16M
P/E (TTM)8.2
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings7.3x
CheapRich

Near the top of its 5-year range · 89th percentile, 5-year average -0.7x

#341 of 2992 stocks by PE (1 = cheapest)

Price / book0.8x
CheapRich

Near the bottom of its 5-year range · 0th percentile, 5-year average 4.0x

#1102 of 5329 stocks by PB (1 = cheapest)

Price / sales0.9x
CheapRich

Near the bottom of its 5-year range · 0th percentile, 5-year average 2,096.4x

#1560 of 5156 stocks by PS (1 = cheapest)

P/E over five years

-38x-3x32x67xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$8.02
Price vs. fair value-34.3%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 0.80 – 4.05 0% (cheaper than usual) #1102 of 5329 (1 = cheapest)
PE 7.28 -33.26 -0.66 89% (pricier than usual) #341 of 2992 (1 = cheapest)
PS 0.90 1.24 2,096.36 0% (cheaper than usual) #1560 of 5156 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on CRMD.

Sign in to join the discussion.

Scroll to Top